{"id":"https://openalex.org/W3164555487","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4842","title":"Long-term Follow-up of Patients with Relapsed or Refractory Non\u2013Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study","display_name":"Long-term Follow-up of Patients with Relapsed or Refractory Non\u2013Hodgkin Lymphoma Treated with Venetoclax in a Phase I, First-in-Human Study","publication_year":2021,"publication_date":"2021-06-03","ids":{"openalex":"https://openalex.org/W3164555487","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4842","mag":"3164555487","pmid":"https://pubmed.ncbi.nlm.nih.gov/34083230","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9401543"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-20-4842","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4842","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-4842","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1158/1078-0432.ccr-20-4842","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachuetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachuetts","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033407869","display_name":"Andrew Warwick Roberts","orcid":"https://orcid.org/0000-0002-7341-5720","observed_orcids":["https://orcid.org/0000-0002-7341-5720","https://orcid.org/0000-0001-5347-7169"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"funder","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I196021976","display_name":"Walter and Eliza Hall Institute of Medical Research","ror":"https://ror.org/01b6kha49","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196021976"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew W. Roberts","raw_affiliation_strings":["2Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","3Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia"],"raw_orcid":"https://orcid.org/0000-0002-7341-5720","affiliations":[{"raw_affiliation_string":"2Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"3Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I196021976"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024909755","display_name":"Vaishalee Padgaonkar Kenkre","orcid":"https://orcid.org/0009-0000-4539-9332","observed_orcids":["https://orcid.org/0009-0000-4539-9332"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vaishalee P. Kenkre","raw_affiliation_strings":["4Division of Hematology and Medical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Division of Hematology and Medical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["5Department of Leukemia, MD Anderson Cancer Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Leukemia, MD Anderson Cancer Center, Houston, Texas","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Abhijeet Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhijeet Kumar","raw_affiliation_strings":["6Division of Hematology and Oncology, University of Arizona Cancer Center, Tuscon, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Hematology and Oncology, University of Arizona Cancer Center, Tuscon, Arizona","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["7Division of Hematology-Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Division of Hematology-Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, San Diego, California","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077126341","display_name":"Michelle Boyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113058","display_name":"Roche (United Kingdom)","ror":"https://ror.org/024tgbv41","country_code":"GB","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113058"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michelle Boyer","raw_affiliation_strings":["8F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom","institution_ids":["https://openalex.org/I4210113058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053884536","display_name":"Ahmed Hamed Salem","orcid":"https://orcid.org/0000-0002-9261-1583","observed_orcids":["https://orcid.org/0000-0002-9261-1583"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Hamed Salem","raw_affiliation_strings":["9AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-9261-1583","affiliations":[{"raw_affiliation_string":"9AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072013221","display_name":"John Carl Pesko","orcid":"https://orcid.org/0000-0002-7568-7762","observed_orcids":["https://orcid.org/0000-0002-7568-7762"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Pesko","raw_affiliation_strings":["9AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0002-7568-7762","affiliations":[{"raw_affiliation_string":"9AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077181688","display_name":"Jennifer A. Arzt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Arzt","raw_affiliation_strings":["9AbbVie Inc., North Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091246313","display_name":"Margaret Mantas","orcid":"https://orcid.org/0000-0003-2829-2757","observed_orcids":["https://orcid.org/0000-0003-2829-2757"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Mantas","raw_affiliation_strings":["9AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0003-2829-2757","affiliations":[{"raw_affiliation_string":"9AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075160341","display_name":"Su Y. Kim","orcid":"https://orcid.org/0000-0001-8059-0482","observed_orcids":["https://orcid.org/0000-0001-8059-0482"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Su Y. Kim","raw_affiliation_strings":["9AbbVie Inc., North Chicago, Illinois"],"raw_orcid":"https://orcid.org/0000-0001-8059-0482","affiliations":[{"raw_affiliation_string":"9AbbVie Inc., North Chicago, Illinois","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081326206","display_name":"John Francis Seymour","orcid":"https://orcid.org/0000-0003-2188-6835","observed_orcids":["https://orcid.org/0000-0003-2188-6835"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"funder","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I196021976","display_name":"Walter and Eliza Hall Institute of Medical Research","ror":"https://ror.org/01b6kha49","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196021976"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John F. Seymour","raw_affiliation_strings":["2Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","3Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia"],"raw_orcid":"https://orcid.org/0000-0003-2188-6835","affiliations":[{"raw_affiliation_string":"2Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"3Department of Medical Biology, University of Melbourne, and Walter and Eliza Hall Institute, Melbourne, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I196021976"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5063755644"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":12.4297,"has_fulltext":false,"cited_by_count":75,"citation_normalized_percentile":{"value":0.99225013,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"27","issue":"17","first_page":"4690","last_page":"4695"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.04540000110864639,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9980000257492065},{"id":"https://openalex.org/keywords/relapsed-refractory-non-hodgkin-lymphoma","display_name":"relapsed/refractory non-Hodgkin lymphoma","score":0.9470000267028809},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9150000214576721},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9229999780654907},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/marginal-zone-lymphoma","display_name":"marginal zone lymphoma","score":0.8790000081062317},{"id":"https://openalex.org/keywords/waldenstrom-macroglobulinemia","display_name":"Waldenstr\u00f6m macroglobulinemia","score":1.0},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.906000018119812},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.9340000152587891},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.8820000290870667},{"id":"https://openalex.org/keywords/hematological-adverse-events","display_name":"hematologic adverse events","score":0.7770000100135803},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.6470000147819519},{"id":"https://openalex.org/keywords/first-in-human","display_name":"first-in-human","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8137885332107544},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.708256721496582},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6810053586959839},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6233285069465637},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5621037483215332},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5474432706832886},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.5297889113426208},{"id":"https://openalex.org/C2776391228","wikidata":"https://www.wikidata.org/wiki/Q4118092","display_name":"Macroglobulinemia","level":3,"score":0.5201200246810913},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.49809789657592773},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.49782896041870117},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.459748774766922},{"id":"https://openalex.org/C2781038049","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Waldenstrom macroglobulinemia","level":3,"score":0.4371039569377899},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.4369533061981201},{"id":"https://openalex.org/C2778563104","wikidata":"https://www.wikidata.org/wiki/Q18553449","display_name":"Marginal zone B-cell lymphoma","level":5,"score":0.42370158433914185},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.3288993835449219},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2762433886528015},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.18942603468894958},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17720559239387512},{"id":"https://openalex.org/C2779921676","wikidata":"https://www.wikidata.org/wiki/Q6760434","display_name":"Marginal zone","level":4,"score":0.17264878749847412},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.1466417908668518},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.12800678610801697},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.10008886456489563},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008258","descriptor_name":"Waldenstrom Macroglobulinemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018442","descriptor_name":"Lymphoma, B-Cell, Marginal Zone","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1158/1078-0432.ccr-20-4842","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4842","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-4842","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9401543","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9401543","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},{"id":"pmid:34083230","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34083230","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt1g8037d3","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/1g8037d3","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, vol 27, iss 17","raw_type":"article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/307858","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11343/307858","pdf_url":null,"source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-20-4842","doi":"https://doi.org/10.1158/1078-0432.ccr-20-4842","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-20-4842","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1970961784","https://openalex.org/W2027728078","https://openalex.org/W2133201432","https://openalex.org/W2144881954","https://openalex.org/W2145676206","https://openalex.org/W2529782638","https://openalex.org/W2582696216","https://openalex.org/W2602734365","https://openalex.org/W2604580699","https://openalex.org/W2795301499","https://openalex.org/W2800133359","https://openalex.org/W2808653175","https://openalex.org/W2883570202","https://openalex.org/W2907818613","https://openalex.org/W2955463869","https://openalex.org/W2987862961","https://openalex.org/W3105196097","https://openalex.org/W3133932532","https://openalex.org/W4233562659"],"related_works":["https://openalex.org/W2912937327","https://openalex.org/W2892307726","https://openalex.org/W2907545704","https://openalex.org/W7108710181","https://openalex.org/W2977159719","https://openalex.org/W2952496787","https://openalex.org/W2531109441","https://openalex.org/W7170243411","https://openalex.org/W2984720282","https://openalex.org/W2582696216"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"We":[2],"previously":[3],"reported":[4],"a":[5,18,120,232,241],"44%":[6],"overall":[7],"response":[8,28,53,110,269],"rate":[9],"(ORR)":[10],"with":[11,34,59,204,222,245],"the":[12,71,128,266],"oral":[13],"BCL-2":[14],"inhibitor":[15],"venetoclax":[16,87],"in":[17,32,56,89,178,240,252],"phase":[19],"I":[20],"study":[21],"of":[22,74,92,109,123,171,243,268],"relapsed/refractory":[23],"non\u2013Hodgkin":[24],"lymphoma":[25,37,45,66],"(NHL).":[26],"Complete":[27],"(CR)":[29],"was":[30,135,155],"observed":[31],"patients":[33,58,82,134,244],"mantle":[35],"cell":[36],"[(MCL),":[38],"21%,":[39],"n":[40,48],"=":[41,49,84],"6/28]":[42],"and":[43,51,63,79,112,149,167,185,201,236,249],"follicular":[44],"[(FL),":[46],"17%,":[47],"5/29],":[50],"partial":[52],"(PR)":[54],"noted":[55],"several":[57],"Waldenstr\u00f6m":[60],"macroglobulinemia":[61],"(WM),":[62],"marginal":[64],"zone":[65],"(MZL).":[67],"Here,":[68],"we":[69],"report":[70],"long-term":[72],"outcomes":[73],"these":[75],"four":[76],"cohorts.":[77],"Patients":[78],"Methods:":[80],"All":[81,191],"(n":[83],"106)":[85],"received":[86],"monotherapy":[88,230],"dose":[90],"cohorts":[91],"200":[93],"to":[94,264,270],"1,200":[95],"mg":[96],"daily":[97],"until":[98],"disease":[99],"progression":[100],"or":[101],"unacceptable":[102],"toxicity.":[103],"ORR,":[104],"progression-free":[105],"survival":[106],"(PFS),":[107],"duration":[108],"(DoR),":[111],"adverse":[113],"events":[114],"(AEs)":[115],"were":[116,195],"evaluated.":[117],"Results:":[118],"At":[119],"median":[121,129,153],"follow-up":[122],"38.5":[124],"months":[125,142,160],"(range,":[126],"30.0\u201346.5),":[127],"PFS":[130],"for":[131],"all":[132],"106":[133],"5.4":[136],"[95%":[137],"confidence":[138],"interval":[139],"(CI),":[140],"3.5\u20138.4]":[141],"(FL,":[143,161],"10.8;":[144],"MCL,":[145,163,247],"11.3;":[146],"MZL,":[147,165,250],"21.2;":[148],"WM,":[150,168,248],"30.4).":[151],"The":[152],"DoR":[154,177],"14.9":[156],"(95%":[157],"CI,":[158],"9.7\u201327.6)":[159],"26.6;":[162],"15.7;":[164],"20.1;":[166],"25.3).":[169],"Achievement":[170],"CR":[172],"versus":[173],"PR":[174],"predicted":[175],"longer":[176],"both":[179],"MCL":[180],"(31.5":[181],"vs.":[182,188],"10.1":[183],"months)":[184],"FL":[186],"(37.6":[187],"9.7":[189],"months).":[190],"grade":[192],"hematologic":[193],"AEs":[194,214],"infrequent:":[196],"neutropenia":[197],"(19%),":[198,200],"anemia":[199],"thrombocytopenia":[202],"(17%),":[203],"no":[205],"new":[206],"cytopenias":[207],"after":[208,225],"2":[209],"years":[210],"on":[211,261],"therapy.":[212],"Nonhematologic":[213],"included":[215],"nausea":[216],"(49%),":[217],"diarrhea":[218],"(46%),":[219],"fatigue":[220],"(44%),":[221],"decreased":[223],"incidence":[224],"1":[226],"year.":[227],"Conclusions:":[228],"Venetoclax":[229],"has":[231],"manageable":[233],"safety":[234],"profile":[235],"achieves":[237],"durable":[238],"responses":[239],"subset":[242],"FL,":[246],"particularly":[251],"those":[253],"who":[254],"achieve":[255],"CR.":[256],"Further":[257],"research":[258],"is":[259],"warranted":[260],"combination":[262],"strategies":[263],"enhance":[265],"durability":[267],"venetoclax.":[271]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":20}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2021-06-07T00:00:00"}